• Info
  • Insider Ownership

Insider Trading & Ownership of Robin L. Smith

Location
Melville, NY
Summary
The estimated net worth of Robin L. Smith is at least $247,415 dollars as of 02 May 2025. Robin L. Smith is the Director of Sorrento Therapeutics, Inc. and owns shares of Sorrento Therapeutics, Inc. stock worth about $188.6K. Robin L. Smith is the Director of Celularity Inc and owns shares of Celularity Inc (CELU) stock worth about $58.8K.
Signature
/s/ Keith A. Kucinski, attorney-in fact for Robin Smith
All Insider Reports
All Insider Reports

Notify me when Robin L. Smith files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Robin L. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SRNEQ Sorrento Therapeutics, Inc. Director $188,635 03 Sep 2021
CELU, CELUW Celularity Inc Director $58,780 14 Jun 2023
MTNB Matinas BioPharma Holdings, Inc. Director 30 Apr 2025
CYCU, CYCUW Cycurion, Inc. Director 11 Jan 2022

Insider Transactions Reported by Robin L. Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.